Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
- PMID: 12509811
- DOI: 10.1002/glia.10132
Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
Abstract
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are common forms of dementia in the elderly associated with cholinergic dysfunction, including reductions in nicotinic acetylcholine receptors (nAChRs). In AD, astrocytes are implicated in the formation of senile plaques, one of the core pathological features. Using immunohistochemistry, we have investigated astrocytic expression of the two major nicotinic receptor alpha subunits in the human hippocampus and entorhinal cortex. alpha7, but not alpha4, subunit immunoreactivity was associated with astrocytes. An increase in the proportion of astrocytes expressing alpha7 immunoreactivity was observed in AD compared with age-matched controls. A similar increase was not evident in DLB. Elevated alpha7 nAChRs on astrocytes in AD may contribute to alterations in calcium homeostasis and nitric oxide production, which in turn could affect beta-amyloid-mediated inflammatory processes in AD.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.J Neurol Sci. 2004 Oct 15;225(1-2):39-49. doi: 10.1016/j.jns.2004.06.015. J Neurol Sci. 2004. PMID: 15465084
-
High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.Exp Neurol. 2005 Mar;192(1):215-25. doi: 10.1016/j.expneurol.2004.12.015. Exp Neurol. 2005. PMID: 15698636
-
Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study.Neuropathol Appl Neurobiol. 2004 Jun;30(3):243-54. doi: 10.1046/j.0305-1846.2003.00528.x. Neuropathol Appl Neurobiol. 2004. PMID: 15175078
-
Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.Biochem Pharmacol. 2011 Oct 15;82(8):931-42. doi: 10.1016/j.bcp.2011.06.039. Epub 2011 Jul 7. Biochem Pharmacol. 2011. PMID: 21763291 Review.
-
α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?Curr Drug Targets. 2012 May;13(5):613-22. doi: 10.2174/138945012800398973. Curr Drug Targets. 2012. PMID: 22300028 Review.
Cited by
-
Developmental Windows for Effects of Choline and Folate on Excitatory and Inhibitory Neurotransmission During Human Gestation.Dev Psychobiol. 2024 Feb;66(2):e22453. doi: 10.1002/dev.22453. Epub 2024 Jan 9. Dev Psychobiol. 2024. PMID: 38646069
-
Ion Channels and Ionotropic Receptors in Astrocytes: Physiological Functions and Alterations in Alzheimer's Disease and Glioblastoma.Life (Basel). 2023 Oct 11;13(10):2038. doi: 10.3390/life13102038. Life (Basel). 2023. PMID: 37895420 Free PMC article. Review.
-
The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.J Neuroinflammation. 2023 May 27;20(1):129. doi: 10.1186/s12974-023-02807-9. J Neuroinflammation. 2023. PMID: 37245024 Free PMC article.
-
The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease.Nat Rev Neurol. 2023 May;19(5):278-288. doi: 10.1038/s41582-023-00792-4. Epub 2023 Mar 28. Nat Rev Neurol. 2023. PMID: 36977843 Review.
-
A Dichotomous Role for FABP7 in Sleep and Alzheimer's Disease Pathogenesis: A Hypothesis.Front Neurosci. 2022 Jun 30;16:798994. doi: 10.3389/fnins.2022.798994. eCollection 2022. Front Neurosci. 2022. PMID: 35844236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
